Benchmark Capital Advisors’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$6K Sell
2018
Q3
$24K Sell
2018
Q2
$27K Sell
2018
Q1
$128K Sell
2017
Q4
$173K Sell
2017
Q3
$185K Hold
2017
Q2
$160K Hold
2017
Q1
$234K Sell
2016
Q4
$236K Sell
2016
Q3
$271K Hold
2016
Q2
$294K Sell
2016
Q1
$274K Buy
2015
Q4
$316K Buy